Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is a good read on uplisting to NASDAQ and others with some historical data behind others who uplisted. The driving force to success appears to be solid fundamentals which I believe OrganiGram has.
https://seekingalpha.com/article/3957442-uplisting-power
This is a good re-entry point to $3
Took profits at 2.55, will get back in soon if it goes lower
I have a positive Outlook on this one today. $2+ easily
5/21 NASDAQ!
This will make a move, no giving up here
Looks like shares are being dumped.
100K at .039. Probably paid a premium but like this long term
All those who said this would lose $3 are eating crow. Some of us knew it was heading to $9
I’m guessing most analysts will reiterate this as a buy without dropping the target pricing. Earnings report came as no surprise to me. Imo
I loaded the boat big time on this one and will continue to do so.
Could be in $9s before open tomorrow.
Hmmmm, wondering if I should bail now with profits or wait until tomorrow.....
For those who got in @.0006 > sorry for under congrats on your flip. This thing is dead now imo
Fund managers are sipping on their coffee and turning on laptops now. Lol
Lol, if I flipped this 4 times this AM I’d be up 50+%. That’s some good profits
May be just PM flipping. We’ll see as volume increases
I’d be surprised if this doesn’t go .75+ today.
Big news here today. FDA approval for anti cancer vaccine
I hold both with same amount of shares in each. OrganiGram to me has a much better chance to outperform ACB. The stock is actually undervalued and will trigger more institutional buying once listed. The eyes are already on this. We just need the right platform for this to trade. Long term, I still like them both.
Most Marijuana stocks are down 3%+ today. This is nothing more than a slight sector correction. ACB is actually holding up better than others.
This will halt at some point. Going nuts!!
Damn, was going to buy PM in low 10’s but did not pull the trigger. Sure many made money on this. Probably will pull back toward open.
News:
Origin House Completes Acquisition of Cub City, Bolstering Craft Cannabis Production Capabilities
NEWS PROVIDED BY
Origin House
May 02, 2019, 08:30 ET
Acquisition of Cub City brings Origin House a 24,600 square foot facility with annual production capacity of up to 1,400 kg of ultra-premium flower, and a team that has cultivated cannabis for some of the top craft flower and pre-roll brands in California.
OTTAWA, May 2, 2019 /CNW/ - CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) ("Origin House" or the "Company"), a North American cannabis products and brands company today announced that it has closed the previously announced acquisition of Cub City LLC ("Cub City"), a licensed premium craft cannabis producer based in Sonoma County, California for total consideration of US$5.3 million (the "Acquisition").
"Access to bespoke cannabis production capacity and related expertise is valuable not just to new cannabis brands but also to heritage, established brands. The addition of Cub City to our cultivation roster strengthens our infrastructure and team in California, making us the partner of choice for brands across the spectrum," commented Marc Lustig, Chairman and CEO of Origin House.
Transaction Highlights
Cub City's 24,600 sq. ft. Santa Rosa facility has an annual production capacity of up to 1,400 kg of ultra-premium flower, along with pre-roll production capabilities.
As previously disclosed, Cub City holds a provisional state indoor cultivation license and a local minor-use permit for cultivation, non-volatile manufacturing, processing and distribution.
Currently undergoing improvements and upgrades, the Cub City facility is expected to be operational in July 2019.
Flower-based products comprise a major segment of the total cannabis market in California. In 2018, flower made up US$974 million, and pre-rolls made up US$1941 million of all cannabis sales in the state. With the Acquisition, Origin House further solidifies its position in the flower market, including the ultra-premium segment targeted by Cub City.
The Acquisition strengthens Origin House's cultivation capabilities through a licensed facility and a skilled production team that has experience cultivating for some of the top craft flower brands in California. Joining the Company under the supervision of Origin House employees Drew and Karen Duval, the team will leverage its expertise and Cub City's proprietary production techniques to produce ultra-premium offerings for the Company's current and prospective brand partners.
__________________________
1 According to data from BDS Analytics.
Related Party Transaction
Pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"), the acquisition of Drew and Karen Duval's membership interests in Cub City constitutes a "related party transaction" as both Drew and Karen are senior employees of the Company. Accordingly, their interests were declared to the Board of Directors (the "Board") of the Company and the Board has considered and approved the Acquisition. At the time the Acquisition was agreed to, the fair market value of the consideration payable by the Company was less than 25% of the market capitalization of the Company. As a result, the Company is relying on the exemptions from the minority shareholder and valuation requirements of MI 61-101 pursuant to Sections 5.5(a) and 5.7(a) of MI 61-101.
About Origin House
Origin House is a growing cannabis brands and distribution company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabis brands. Origin House's foundation is in California, the world's largest regulated cannabis market, where it delivers over 130 branded cannabis products from 50+ brands to the majority of licensed dispensaries. Origin House's brand development platform is operated out of five licensed facilities located across California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners. Origin House is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke. Origin House's shares trade on the CSE under the symbol "OH" and on the OTCQX under the symbol "ORHOF". Origin House is the registered business name of CannaRoyalty Corp. For more information, visit www.originhouse.com.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Origin House's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward- looking statements.
One thing that is apparent in this industry is that analysts target prices mean Jack. Once this is listed we will see much higher PPS. $40 - 50 + imo
I agree 100% with what you are saying. I’m here long term as with others.
Mull this over.....
Canopy Growth is valued at $3.90 with higher SS than OrganiGram yet trades $50+. OrganiGram is fully valued at around $8.90. This hits Nasdaq we are looking at $50+ easily. The big fish will invest once listed. Load the boat now and you will be buying a yacht!
They need to reduce share count. This could easily be $40 - $50. Too many shares.
It’s holding up good as we inch toward opening. Could be interesting.
Origin House Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2018
CNW Group
CNW GroupApril 29, 2019, 7:30 AM EDT
On April 1, 2019 , the Company entered into a definitive agreement to be acquired by Cresco Labs for $1.1 billion , creating a North American cannabis powerhouse.
Record Q4 revenue of $7.9 million ; + 19% vs. Q3 2018 and +638% vs. Q4 2017, driven by distribution revenues and product sales across all cannabis product categories.
Acquired Kaya Manufacturing, Alta Supply, RVR Distribution, FloraCal Farms and 180 Smoke in 2018 to create a footprint today comprised of 6 licenses, 8 facilities and over 350 employees in California and Canada , with pro-forma revenue of $37.4 million . Pro-forma revenue reached $48.7 million with the acquisition of 180 Smoke in Q1 2019.
Integrated two of the largest and most important distributors in California – RVR Distribution and Alta Supply – now operating as a statewide network under the Continuum banner with more than 50 brand relationships and over 1,000 SKUs in more than 500 dispensaries and greater than 60% penetration1 in licensed dispensaries in California .
The Company's Brand Accelerator Program initiated in Q4 2018 and other strategic brand partnerships have added dynamic brands to the platform including King's Garden, Henry's Original, Utopia Cannabis, Pacific Remedy, Kurvana, Humboldt's Finest, Viola Brands and Papa's Herb.
Exited the year with a cash position of $69.2 million as of December 31, 2018 .
OTTAWA , April 29, 2019 /CNW/ - CannaRoyalty Corp. d/b/a Origin House (OH.CN) (ORHOF) ("Origin House" or the "Company"), a leading North American cannabis products and brands company, announced today the Company's financial results for the three months and year ended December 31, 2018 . All figures are reported in Canadian dollars ($), unless otherwise indicated. Origin House's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
Good news today. Could see a pop.
Wowza
Wow, wonder what the bottom is here or is there no bottom?? Lol
Man, the cheap shots are not necessary. Move on if you don’t like this play.
Seems like it may be still diluting.
Up 2+%, profit taking at open inevitable. It will consolidate and rise.
Looks like $2+ is very attainable in the near future imo
In at .78